NFKB2 and lung carcinoma: They also suggested that the reduced tumoricidal ability of NF-κB2–deficient T cells has been overcome in NF-κB2–KO mice, externally by NF-κB2 deficiency in immune cells other than T cells and B cells, for lung cancer suppression.